Insider Transactions in Q4 2020 at Invitae Corp (NVTA)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Sean E George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.54%
|
$10,000
$1.26 P/Share
|
|
Dec 24
2020
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,622
-1.16%
|
$181,100
$50.5 P/Share
|
|
Dec 24
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
48,971
-2.21%
|
$2,350,608
$48.85 P/Share
|
|
Dec 23
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
125,181
-5.7%
|
$6,509,412
$52.9 P/Share
|
|
Dec 22
2020
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
3,675
-0.19%
|
$191,100
$52.85 P/Share
|
|
Dec 22
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
124,991
-4.65%
|
$6,624,523
$53.07 P/Share
|
|
Dec 21
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
99,974
-2.54%
|
$4,798,752
$48.93 P/Share
|
|
Dec 18
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
131,351
-4.82%
|
$6,304,848
$48.11 P/Share
|
|
Dec 17
2020
|
Jason W. Myers Director |
SELL
Bona fide gift
|
Direct |
300,000
-24.17%
|
-
|
|
Dec 17
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
50,692
-1.32%
|
$2,382,524
$47.38 P/Share
|
|
Dec 16
2020
|
Kenneth D. Knight Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,351
-4.11%
|
$680,901
$51.0 P/Share
|
|
Dec 16
2020
|
Eric Aguiar Director |
SELL
Open market or private sale
|
Direct |
10,000
-82.0%
|
$510,000
$51.11 P/Share
|
|
Dec 16
2020
|
Eric Aguiar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$240,000
$24.16 P/Share
|
|
Dec 16
2020
|
Jason W. Myers Director |
SELL
Open market or private sale
|
Direct |
71,869
-5.27%
|
$3,377,843
$47.32 P/Share
|
|
Dec 14
2020
|
Jason W. Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
324,399
+11.24%
|
-
|
|
Dec 14
2020
|
Katherine Stueland Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
34,300
-2.2%
|
$1,955,100
$57.97 P/Share
|
|
Nov 24
2020
|
Robert F. Werner Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,427
-0.81%
|
$118,923
$49.59 P/Share
|
|
Nov 20
2020
|
Sean E George Director |
SELL
Open market or private sale
|
Direct |
8,683
-0.45%
|
$408,101
$47.85 P/Share
|
|
Nov 20
2020
|
Sean E George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.77%
|
$40,000
$8.7 P/Share
|
|
Nov 18
2020
|
Shelly D Guyer Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-0.44%
|
$141,000
$47.09 P/Share
|
|
Nov 17
2020
|
Thomas Brida |
SELL
Open market or private sale
|
Direct |
5,000
-1.18%
|
$230,000
$46.17 P/Share
|
|
Nov 16
2020
|
Eric Aguiar Director |
SELL
Open market or private sale
|
Direct |
30,000
-88.14%
|
$1,380,000
$46.71 P/Share
|
|
Nov 16
2020
|
Eric Aguiar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+36.11%
|
$270,000
$9.61 P/Share
|
|
Nov 13
2020
|
Katherine Stueland Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.42%
|
$48,000
$48.0 P/Share
|
|
Oct 13
2020
|
Katherine Stueland Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.42%
|
$51,000
$51.36 P/Share
|
|
Oct 09
2020
|
Robert L Nussbaum Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,550
+2.95%
|
$58,950
$9.9 P/Share
|
|
Oct 05
2020
|
Robert F. Werner Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+33.21%
|
-
|
|
Oct 02
2020
|
Jason W. Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,039,227
+50.0%
|
-
|